San Martin Javier
Insider CIK 1794629 · ATHA CHIEF MEDICAL OFFICER · ARWR Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-04-13 | 350,000 | — | $0 | 350,000 | SEC↗ |
| LONA LeonaBio, Inc. | S Sale | 2026-03-04 | 2026-03-05 | 1,720 | $5.37 | $9.2K | 15,887 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise deriv | 2026-03-03 | 2026-03-05 | 7,418 | — | $0 | 0 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise | 2026-03-03 | 2026-03-05 | 7,418 | — | $0 | 17,607 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 1,644 | $6.88 | $11.3K | 10,189 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 4,667 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 4,667 | — | $0 | 11,833 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-24 | 2025-12-29 | 44,508 | — | $0 | 44,508 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-02 | 10,842 | $0.29 | $3.1K | 71,665 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-06-30 | 2025-07-02 | 46,666 | — | $0 | 46,667 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-06-30 | 2025-07-02 | 46,666 | — | $0 | 82,507 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 74,180 | — | $0 | 74,180 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 111,270 | — | $0 | 111,270 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 10,826 | $0.56 | $6.1K | 35,841 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 46,667 | — | $0 | 93,333 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 46,667 | — | $0 | 46,667 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-04-15 | 2024-04-16 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-05 | 2024-01-08 | 800 | $34.11 | $27.3K | 206,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-05 | 2024-01-08 | 3,100 | $35.03 | $108.6K | 202,900 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-01-05 | 2024-01-08 | 4,403 | $35.64 | $156.9K | 198,497 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2024-01-04 | 2024-01-08 | 75,000 | — | $0 | 206,800 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-11-20 | 2023-11-22 | 4,942 | $29.00 | $143.3K | 131,800 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-11-20 | 2023-11-22 | 14,758 | $28.73 | $424.0K | 136,742 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-01-04 | 2023-01-05 | 60,000 | — | $0 | 151,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-11-21 | 2022-11-22 | 19,300 | $29.98 | $578.6K | 91,700 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-11-21 | 2022-11-22 | 200 | $30.62 | $6.1K | 91,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-11-19 | 2021-11-22 | 100 | $70.99 | $7.1K | 111,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-11-19 | 2021-11-22 | 5,696 | $70.01 | $398.8K | 111,100 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-11-19 | 2021-11-22 | 13,704 | $69.01 | $945.7K | 116,796 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-11-19 | 2020-11-20 | 19,500 | $69.39 | $1.35M | 130,500 | SEC↗ |